Community benchmarks for virtual screening

Article

Abstract

Ligand enrichment among top-ranking hits is a key metric of virtual screening. To avoid bias, decoys should resemble ligands physically, so that enrichment is not attributable to simple differences of gross features. We therefore created a directory of useful decoys (DUD) by selecting decoys that resembled annotated ligands physically but not topologically to benchmark docking performance. DUD has 2950 annotated ligands and 95,316 property-matched decoys for 40 targets. It is by far the largest and most comprehensive public data set for benchmarking virtual screening programs that I am aware of. This paper outlines several ways that DUD can be improved to provide better telemetry to investigators seeking to understand both the strengths and the weaknesses of current docking methods. I also highlight several pitfalls for the unwary: a risk of over-optimization, questions about chemical space, and the proper scope for using DUD. Careful attention to both the composition of benchmarks and how they are used is essential to avoid being misled by overfitting and bias.

Keywords

Virtual screening Benchmarking Enrichment Decoys 

References

  1. 1.
    Verdonk ML, Cole JC, Hartshorn MJ, Murray CW, Taylor RD (2003) Improved protein-ligand docking using GOLD. Proteins 52:609–623CrossRefGoogle Scholar
  2. 2.
    Abagyan RA, Totrov MM, Kuznetsov DA (1994) ICM: a new method for structure modeling and design. J Comput Chem 14:488–506CrossRefGoogle Scholar
  3. 3.
    Meng EC, Shoichet BK, Kuntz ID (1992) Automated docking with grid-based energy evaluation. J Comput Chem 13:505–524CrossRefGoogle Scholar
  4. 4.
    McGann MR, Almond HR, Nicholls A, Grant JA, Brown FK (2003) Gaussian docking functions. Biopolymers 68:76–90CrossRefGoogle Scholar
  5. 5.
    Friesner RA et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739–1749CrossRefGoogle Scholar
  6. 6.
    Rarey M, Kramer B, Lengauer T, Klebe G (1996) A fast flexible docking method using an incremental construction algorithm. J Mol Biol 261:470–489CrossRefGoogle Scholar
  7. 7.
    Miller MD, Kearsley SK, Underwood DJ, Sheridan RP (1994) FLOG: a system to select ‘quasi-flexible’ ligands complementary to a receptor of known three-dimensional structure. J Comput Aided Mol Des 8:153–174CrossRefGoogle Scholar
  8. 8.
    Perola E, Walters WP, Charifson PS (2004) A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance. Proteins 56:235–249CrossRefGoogle Scholar
  9. 9.
    Ferrara P, Gohlke H, Price DJ, Klebe G, Brooks CL III (2004) Assessing scoring functions for protein-ligand interactions. J Med Chem 47:3032–3047CrossRefGoogle Scholar
  10. 10.
    Kellenberger E, Rodrigo J, Muller P, Rognan D (2004) Comparative evaluation of eight docking tools for docking and virtual screening accuracy. Proteins 57:225–242CrossRefGoogle Scholar
  11. 11.
    Kontoyianni M, McClellan LM, Sokol GS (2004) Evaluation of docking performance: comparative data on docking algorithms. J Med Chem 47:558–565CrossRefGoogle Scholar
  12. 12.
    Wang R, Lu Y, Fang X, Wang S (2004) An extensive test of 14 scoring functions using the PDBbind refined set of 800 protein-ligand complexes. J Chem Inf Comput Sci 44:2114–2125CrossRefGoogle Scholar
  13. 13.
    Verdonk ML et al (2004) Virtual screening using protein-ligand docking: avoiding artificial enrichment. J Chem Inf Comput Sci 44:793–806CrossRefGoogle Scholar
  14. 14.
    Xing L, Hodgkin E, Liu Q, Sedlock D (2004) Evaluation and application of multiple scoring functions for a virtual screening experiment. J Comput Aided Mol Des 18:333–344CrossRefGoogle Scholar
  15. 15.
    Onodera K, Satou K, Hirota H (2007) Evaluations of molecular docking programs for virtual screening. J Chem Inf Model 47:1609–1618CrossRefGoogle Scholar
  16. 16.
    Zhou Z, Felts AK, Friesner RA, Levy RM (2007) Comparative performance of several flexible docking programs and scoring functions: enrichment studies for a diverse set of pharmaceutically relevant targets. J Chem Inf Model 47:1599–1608CrossRefGoogle Scholar
  17. 17.
    Hartshorn MJ et al (2007) Diverse, high-quality test set for the validation of protein-ligand docking performance. J Med Chem 50:726–741CrossRefGoogle Scholar
  18. 18.
    Nissink JW et al (2002) A new test set for validating predictions of protein-ligand interaction. Proteins 49:457–471CrossRefGoogle Scholar
  19. 19.
    Kuntz ID, Chen K, Sharp KA, Kollman PA (1999) The maximal affinity of ligands. Proc Natl Acad Sci USA 96:9997–10002CrossRefGoogle Scholar
  20. 20.
    Pham TA, Jain AN (2006) Parameter estimation for scoring protein–ligand interactions using negative training data. J Med Chem 49:5856–5868Google Scholar
  21. 21.
    Bissantz C, Folkers G, Rognan D (2000) Protein-based virtual screening of chemical databases: 1. evaluation of different docking/scoring combinations. J Med Chem 43:4759–4767CrossRefGoogle Scholar
  22. 22.
    Irwin JJ, Shoichet BK (2005) ZINC–a free database of commercially available compounds for virtual screening. J Chem Inf Model 45:177–182CrossRefGoogle Scholar
  23. 23.
    Halgren TA et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 47:1750–1759CrossRefGoogle Scholar
  24. 24.
    Gohlke H, Hendlich M, Klebe G (2000) Knowledge-based scoring function to predict protein-ligand interactions. J Mol Biol 295:337–356CrossRefGoogle Scholar
  25. 25.
    Ferrari AM, Wei BQ, Costantino L, Shoichet BK (2004) Soft docking and multiple receptor conformations in virtual screening. J Med Chem 47:5076–5084CrossRefGoogle Scholar
  26. 26.
    van Drie JH (2003) Pharmacophore discovery–lessons learned. Curr Pharm Des 9:1649–1664CrossRefGoogle Scholar
  27. 27.
    Brünger A (1992) The free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 355:472–474Google Scholar
  28. 28.
    Byvatov E, Schneider G (2003) Support vector machine applications in bioinformatics. Appl Bioinformatics 2:67–77Google Scholar
  29. 29.
    Kleywegt GJ (2007) Separating model optimization and model validation in statistical cross-validation as applied to crystallography. Acta Crystallogr D Biol Crystallogr 63:939–940Google Scholar
  30. 30.
    Graves AP, Brenk R, Shoichet BK (2005) Decoys for docking. J Med Chem 48:3714–3728CrossRefGoogle Scholar
  31. 31.
    Fink T, Reymond JL (2007) Virtual exploration of the chemical universe up to 11 atoms of C, N, O, F: assembly of 26.4 million structures (110.9 million stereoisomers) and analysis for new ring systems, stereochemistry, physicochemical properties, compound classes, and drug discovery. J Chem Inf Model 47:342–353CrossRefGoogle Scholar
  32. 32.
    Hann MM, Oprea TI (2004) Pursuing the leadlikeness concept in pharmaceutical research. Curr Opin Chem Biol 8:255–263CrossRefGoogle Scholar
  33. 33.
    James CA (2007) Daylight Theory Manual 4.93Google Scholar
  34. 34.
    Overington JP, Al-Lazikani B, Hopkins AL (2006) How many drug targets are there? Nat Rev Drug Discov 5:993–996CrossRefGoogle Scholar
  35. 35.
    Cherezov V et al (2007) High-Resolution Crystal Structure of an Engineered Human {beta}2-Adrenergic G Protein Coupled Receptor. Science 366Google Scholar
  36. 36.
    Yohannan S, Hu Y, Zhou Y (2007) Crystallographic study of the tetrabutylammonium block to the KcsA K+ channel. J Mol Biol 366:806–814CrossRefGoogle Scholar
  37. 37.
    Xiong JP et al (2002) Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. Science 296:151–155CrossRefGoogle Scholar
  38. 38.
    Berman HM et al (2000) The protein data bank. Nucl Acid Res 28:235–242CrossRefGoogle Scholar
  39. 39.
    Benson ML, Smith RD, Khazanov NA, Dimcheff B, Beaver J, Dresslar P, Nerothin J, Carlson HA (2008) Binding MOAD, a high-quality protein-ligand database. NAR 36:D674–D678Google Scholar
  40. 40.
    Liu T, Lin Y, Wen X, Jorissen RN, Gilson MK (2007) BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Res 35:D198–201CrossRefGoogle Scholar
  41. 41.
    Zhang J et al (2004) Development of KiBank, a database supporting structure-based drug design. Comput Biol Chem 28:401–407CrossRefGoogle Scholar
  42. 42.
    Good AC, Oprea TI (2008) Optimization of CAMD techniques 3. Virtual screening enrichment studies: a help or hindrance in tool selection? J Comput Aided Mol Des this issue, doi:10.1007/s10822-007-9167-2

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  1. 1.Department of Pharmaceutical ChemistryUniversity of California San FranciscoSan FranciscoUSA

Personalised recommendations